Last reviewed · How we verify
NCT04760938
Treating Adolescents With CBT and OBH
NA trial testing Outdoor Behavioral Healthcare (OBH) in Anxiety Disorders in 10 participants. Terminated before completion.
1 December 2021
Quick facts
| Lead sponsor | University of New Hampshire |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 February 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Outdoor Behavioral Healthcare (OBH)
- Cognitive Behavioral Therapy (CBT)
Conditions studied
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Depressive Disorder — all drugs for Depressive Disorder →
- Substance Use Disorders — all drugs for Substance Use Disorders →
Sponsor
University of New Hampshire
Who can join
Adults 13 to 17, any sex, with Anxiety Disorders or Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine various behavioral, social, and emotional changes that result from engaging in an OBH and CBT treatment program designed for adolescents.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04760938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders
Currently open trials in the same condition.
- NCT07340281 — Biomarkers for Exercise · NA · recruiting
- NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
- NCT07316374 — AI Chatbots for Anxiety Mental Health Literacy · NA · active not recruiting
- NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
- NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting
Other University of New Hampshire trials
Trials by the same sponsor.
- NCT07503912 — Evaluation of the Not A Number Trafficking Prevention Program in Minnesota · NA · not yet recruiting
- NCT05336955 — Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities · NA · recruiting
- NCT05912348 — The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults · NA · recruiting
- NCT05488912 — Fiber-rich Foods, Weight Status, and the Gut Microbiota in NH Hispanic Adults at Risk for Food Insecurity · completed
- NCT05424367 — Food Environment, Food Insecurity, and Health Behaviors in NH Hispanics · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04760938 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of New Hampshire
- Last refreshed: 18 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04760938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing